01.02.2019, 00:16
Healthcare | Biotechnology | USA
Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001)
Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002)
Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004)
New Phase 2a Trial in Infants and Children with Acute Otitis Media Planned for 2019 (Study C-006)
...
NVUS heute + 41% ...
![[Bild: NVUSc1dl1715.png]](https://finviz.com/publish/013119/NVUSc1dl1715.png)
Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials
Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001)
Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002)
Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004)
New Phase 2a Trial in Infants and Children with Acute Otitis Media Planned for 2019 (Study C-006)
...
NVUS heute + 41% ...